Cargando…
Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria
As an emerging minimally invasive treatment method, percutaneous ablation is more and more widely used in the treatment of liver tumors. It has been recommended by guidelines for diagnosis and treatment of hepatocellular carcinoma (HCC) as a curative treatment alongside surgical resection and liver...
Autores principales: | Zhou, Yanzhao, Yang, Yi, Zhou, Bingyan, Wang, Zhengzheng, Zhu, Ruili, Chen, Xun, Ouyang, Jingzhong, Li, Qingjun, Zhou, Jinxue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232857/ https://www.ncbi.nlm.nih.gov/pubmed/34189133 http://dx.doi.org/10.2147/JHC.S298709 |
Ejemplares similares
-
Recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors
por: Chen, Rui, et al.
Publicado: (2023) -
Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis
por: Ouyang, Jingzhong, et al.
Publicado: (2023) -
Gallbladder cancer: current and future treatment options
por: Zhou, Yanzhao, et al.
Publicado: (2023) -
Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study
por: Yang, Yi, et al.
Publicado: (2021) -
Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery
por: Shiina, Shuichiro, et al.
Publicado: (2018)